Rhythm Pharmaceuticals Inc (RYTM)
Stock-Based Compensation
$49.16M
Quarterly · Period ending: · USD
RYTM Stock-Based Compensation
Latest reported$49.16Mperiod ending
Latest reported$49.16Mperiod ending
RYTM Quarterly Stock-Based Comp ($22.00K → $49.16M)
Quarterly stock-based compensation
High-resolution chart · PNG
RYTM stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 49,155,000 | |
| 23,099,000 | |
| 19,266,000 | |
| 18,810,000 | |
| 15,880,000 | |
| 12,862,000 | |
| 10,556,000 | |
| 11,001,000 | |
| 10,358,000 | |
| 7,767,000 | |
| 8,674,000 | |
| 8,612,000 | |
| 8,891,000 | |
| 6,376,000 | |
| 5,287,000 | |
| 4,796,000 | |
| 5,137,000 | |
| 4,611,000 | |
| 4,676,000 | |
| 5,268,000 | |
| 5,669,000 | |
| 5,191,000 | |
| 4,257,000 | |
| 4,695,000 | |
| 3,028,000 | |
| 5,475,000 | |
| 2,924,000 | |
| 3,035,000 | |
| 3,272,000 | |
| 2,644,000 | |
| 2,023,000 | |
| 1,893,000 | |
| 1,516,000 | |
| 958,000 | |
| 709,000 | |
| 871,000 | |
| 434,000 | |
| 264,000 | |
| 309,000 | |
| 300,000 | |
| 277,000 | |
| 282,000 | |
| 233,000 | |
| 42,000 | |
| 11,500 | |
| 11,500 | |
| 7,000 | |
| 15,000 | |
| 22,000 | |
| 22,000 |